BUY Gland Pharma Limited — Sudeep Shah, SBICAP Securities
bySudeep Shah, SBICAP SecuritiesHorizon: NA (inferred Swing (≤2wk))11 Jun 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·20 May · 3w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Gland Pharma
- BUY — Vishnu Kant Upadhyay, Master Capital Services13 Oct 2026 · ~3 months · target ₹3,400 · Active
- BUY — Kunal Parar, Choice Broking8 Oct 2026 · Same day · target ₹3,235 · Expired
- BUY — Prakash Gaba7 Oct 2026 · ~2 weeks · target ₹3,200 · SL hit
- BUY — Nomura India Research7 Oct 2026 · ~1 year · target ₹3,750 · Active
- BUY — Raja Venkatraman7 Oct 2026 · ~3 months · target ₹3,325 · SL hit
More from Sudeep Shah, SBICAP Securities
- BUY Action Construction Equipment22 Oct 2026 · ~2 weeks · target ₹1,115 · SL hit
- BUY CRISIL22 Oct 2026 · ~3 months · target ₹4,750 · Target hit
- BUY Stove Kraft21 Oct 2026 · ~3 months · target ₹900 · SL hit
- BUY DCB Bank19 Oct 2026 · ~2 weeks · target ₹226 · Active
- BUY Union Bank of India19 Oct 2026 · ~2 weeks · target ₹183 · Target hit

